Researchers Identified Natural RNA Modifications in Archaea
The discovery of natural phosphorothioate modifications in hyperthermophilic archaea informs future RNA-based therapeutics.
Updated on Oct. 13, 2026 in Life Sciences
Live Poll
Should medical research prioritize developing new RNA-based therapeutics based on discoveries in extremophile organisms?
In research published in August 2026, scientists identified natural RNA phosphorothioate modifications within hyperthermophilic archaea. The study found that these modifications vary based on environmental conditions and uncovered the writer machinery responsible for their creation.
Why it matters
The identification of this biological mechanism provides a new tool for synthetic biology, potentially enabling the engineering of more stable RNA molecules. These findings offer a new framework for advancing the development of RNA-based therapeutics.
The study, published with DOI 10.1016/j.cell.2026.08.034, demonstrates that these modifications are not static but change in response to environmental conditions. Researchers isolated these specific molecules from extremophilic strains provided by the German Archaea Center.
The players
University of Regensburg
A German public research university that maintains the German Archaea Center and hosts significant extremophile biological studies.
Weizmann Institute of Science
A public research university in Rehovot, Israel, specializing in multidisciplinary science and fundamental molecular research.
The details
Researchers utilized cultivation and RNA analysis techniques to examine various extremophilic archaea—organisms that thrive in extreme physical or chemical conditions. By isolating RNA molecules, they mapped the presence of phosphorothioates, a chemical modification where a sulfur atom replaces an oxygen atom in the RNA backbone. The team successfully identified the specific writer machinery—the enzyme systems that catalyze these molecular changes—across these hyperthermophilic strains.
Timeline
The research findings were published in the journal Cell in August 2026.
A press release detailing these findings was issued on October 13, 2026.
The Tech Race
This discovery places researchers at the forefront of understanding how extreme organisms maintain genetic stability. By identifying these natural enzymes, the work follows a track set by efforts to improve the chemical durability of therapeutic mRNA.
This development currently exists in the research stage and does not offer immediate applications for clinical or consumer therapeutics. Its long-term value lies in providing synthetic biology teams with new enzymatic templates to increase the stability of RNA-based drug delivery systems.
The takeaway
The discovery reveals that nature has already evolved complex mechanisms for stabilizing RNA backbones using sulfur. Future work will focus on whether these natural writer enzymes can be successfully repurposed to increase the half-life of synthetic RNA vaccines and therapies.
Further reading
For more on the latest research in molecular biology, explore the Life Sciences section.
Source note: This article includes information reported by Informationdienst Wissenschaft e.V. - idw.
Live Poll
Should medical research prioritize developing new RNA-based therapeutics based on discoveries in extremophile organisms?
